Related Experiment Video
Updated: Jan 17, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Colorectal Neoplasia Pathogenesis in Normal Appearing Colonic Mucosa -A Perspective With Focus on Eicosanoid
Ulrike Ries Feddersen1,2, Sebastian Kjærgaard Hendel1,3, Victoria Hellen Berner-Hansen1
1Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Identifying early colorectal neoplasia (CRN) risk is vital for prevention. This review highlights arachidonic acid pathways and COX-1 enzyme in CRN pathogenesis, suggesting future drug targets for colorectal cancer (CRC).
Area of Science:
- Gastroenterology and Oncology
- Molecular Biology
- Cancer Pathogenesis
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality, with increasing incidence.
- Early detection and prevention are crucial for improving CRC outcomes.
- Understanding colorectal neoplasia (CRN) pathogenesis and identifying high-risk individuals are key for targeted surveillance and prevention.
Purpose of the Study:
- To review signaling pathways, biomarkers, and pharmacological targets in CRN pathogenesis.
- To present novel research on fresh colonic biopsies from normal-appearing mucosa.
- To investigate alterations in enzymes, receptors, and transporters involved in CRN development.
Main Methods:
- Analysis of fresh colonic biopsies from patients with and without CRN.
- Focus on arachidonic acid signaling pathways.
- Examination of enzyme, receptor, and transporter function, expression, and location.
Main Results:
- Identified alterations in enzymes, receptors, and transporters within normal colonic mucosa.
- Highlighted the role of arachidonic acid signaling in CRN pathogenesis.
- Observed implications of the COX-1 enzyme in CRN development.
Conclusions:
- Suggests specific research areas and drug development targets for CRN and CRC prevention/treatment.
- Emphasizes the importance of studying normal-appearing mucosa for early detection insights.
- Provides a foundation for future therapeutic strategies targeting CRN and CRC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Ulcerative Colitis in IBD

